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Introduction	  Prematurity	  remains	  a	  significant	  problem	  in	  the	  United	  States.	  In	  2013,	  approximately	  447,000	  infants	  were	  born	  premature.	  Of	  those,	  28,000	  were	  extremely	  premature	  (less	  than	  29	  weeks	  gestation)	  (NVSS,	  2015).	  These	  infants	  are	  at	  high	  risk	  for	  a	  number	  of	  complications.	  Fortunately,	  survival	  rates	  are	  significantly	  improving.	  However,	  it	  is	  now	  necessary	  to	  begin	  to	  focus	  on	  improving	  overall	  health	  outcomes	  for	  these	  infants.	  Growth	  is	  one	  area	  receiving	  increased	  attention	  because	  of	  its	  relationship	  to	  long-­‐term	  outcomes	  (Sammallahti	  et	  al.,	  2015).	  Although	  the	  majority	  of	  premature	  infants	  are	  born	  at	  an	  appropriate	  weight	  (10th-­‐90th	  percentile)	  for	  their	  gestational	  age	  and	  sex,	  many	  will	  develop	  extrauterine	  growth	  retardation	  (EUGR)	  and	  will	  be	  discharged	  from	  the	  neonatal	  intensive	  care	  unit	  (NICU)	  with	  growth	  measurements	  at	  or	  below	  the	  10th	  percentile	  (Ehrenkranz,	  2014).	  This	  suggests	  that	  growth	  in	  the	  NICU	  is	  inadequate	  and	  ways	  to	  promote	  growth	  throughout	  the	  hospital	  stay	  need	  to	  be	  further	  investigated	  given	  the	  significant	  length	  of	  stay	  for	  many	  premature	  infants.	  	  While	  much	  of	  the	  research	  effort	  is	  focused	  on	  the	  relationship	  between	  nutritional	  management	  and	  growth,	  one	  area	  worth	  exploring	  is	  the	  impact	  of	  the	  stressful	  NICU	  environment	  on	  growth.	  Premature	  infants	  are	  exposed	  to	  frequent	  handling	  and	  a	  variety	  of	  painful	  procedures,	  especially	  during	  the	  first	  few	  days	  of	  life	  when	  infants	  are	  acutely	  ill,	  that	  are	  stressful	  to	  these	  vulnerable	  infants.	  Limited	  evidence	  shows	  an	  inverse	  relationship	  between	  the	  number	  of	  painful	  procedures	  a	  premature	  infant	  experiences	  in	  the	  NICU	  and	  subsequent	  weight	  gain	  (Vinall	  et	  al.,	  2012).	  This	  suggests	  that	  examining	  the	  effects	  of	  stress	  on	  growth	  in	  premature	  infants	  will	  allow	  for	  the	  development	  of	  strategies	  to	  decrease	  stress	  and	  support	  growth.	  There	  may	  be	  a	  biobehavioral	  contribution	  to	  a	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  premature	  infant’s	  growth.	  Limited	  findings	  from	  animal	  models	  have	  suggested	  that	  at	  certain	  physiologic	  levels,	  oxytocin	  dampens	  the	  stress	  response,	  as	  well	  as	  promotes	  weight	  gain	  through	  the	  release	  of	  growth	  hormone	  (Björkstrand,	  Hulting,	  Uvnäs-­‐Moberg,	  1997).	  This	  relationship	  is	  still	  not	  well	  understood	  and	  has	  not	  yet	  been	  studied	  in	  premature	  infants.	  
Purpose	  of	  Study	  The	  purpose	  of	  this	  exploratory	  study	  was	  to	  determine	  the	  relationship	  between	  oxytocin	  and	  weight	  gain	  in	  premature	  infants.	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Importance	  of	  Growth	  in	  Neonates	  Promoting	  growth	  in	  the	  NICU	  has	  been	  a	  well-­‐known	  challenge	  throughout	  the	  years.	  By	  discharge,	  many	  premature	  infants,	  especially	  extremely	  premature	  infants,	  will	  develop	  extrauterine	  growth	  retardation	  (EUGR).	  Extrauterine	  growth	  retardation	  is	  typically	  defined	  as	  a	  growth	  measurement	  (weight,	  length,	  or	  head	  circumference)	  that	  is	  below	  the	  10th	  percentile	  of	  the	  expected	  intrauterine	  growth	  for	  the	  postmenstrual	  age	  (PMA)	  (Ehrenkranz,	  2014).	  Stoll	  et	  al.	  (2010),	  in	  their	  study,	  demonstrated	  that	  79%	  of	  extremely	  premature	  infants	  had	  attained	  weights	  less	  than	  the	  10th	  percentile	  by	  36	  weeks	  PMA.	  A	  significant	  number	  of	  extremely	  premature	  infants	  exhibit	  a	  decrease	  in	  standard	  deviation	  scores	  by	  discharge	  (Franz	  et	  al.,	  2009).	  These	  findings	  are	  further	  supported	  by	  the	  findings	  from	  Frondas-­‐Chauty	  and	  colleagues	  (2014).	  In	  a	  large	  cohort	  study,	  these	  researchers	  demonstrated	  that	  66%	  of	  premature	  infants	  experienced	  a	  decrease	  in	  the	  z-­‐score	  for	  weight	  of	  at	  least	  -­‐0.51	  between	  birth	  and	  discharge	  from	  the	  NICU.	  The	  findings	  from	  these	  studies	  provide	  evidence	  that	  EUGR	  is	  an	  important	  problem	  for	  premature	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  infants.	  Due	  to	  the	  increased	  survival	  rates	  of	  premature	  infants,	  it	  is	  essential	  to	  also	  focus	  on	  improving	  growth	  in	  order	  to	  improve	  long-­‐term	  outcomes	  (Steward,	  2012).	  EUGR	  can	  place	  these	  infants	  at	  risk	  for	  many	  complications	  and	  most	  importantly	  impact	  their	  neurodevelopment.	  	  
Relationship	  between	  Neonatal	  Pain	  and	  Growth	  	  Unfortunately,	  pain	  is	  a	  crucial	  component	  of	  life-­‐saving	  care	  in	  the	  NICU.	  However,	  it	  has	  also	  been	  proposed	  that	  painful	  procedures	  is	  a	  significant	  contributor	  to	  the	  stress	  experienced	  by	  premature	  infants.	  Researchers	  have	  demonstrated	  that	  premature	  infants	  experience,	  on	  average,	  12	  painful	  or	  stressful	  procedures	  per	  day	  (Carbajal	  et	  al.,	  2008;	  Roofthooft,	  Simons,	  Anand,	  Tibboel,	  &	  van	  Dijk,	  2014).	  Importantly,	  the	  stress	  surrounding	  pain	  is	  hypothesized	  to	  be	  a	  factor	  directly	  impacting	  growth	  and	  development.	  The	  minimal	  evidence	  available	  suggests	  that	  there	  is	  an	  important	  relationship	  between	  procedural	  pain	  and	  growth	  in	  premature	  infants.	  According	  to	  a	  study	  by	  Vinall	  et	  al.,	  (2012),	  neonatal	  procedural	  pain	  was	  associated	  with	  delayed	  post-­‐natal	  body	  and	  head	  growth	  in	  the	  NICU,	  independent	  of	  other	  medical	  confounders.	  These	  researchers	  also	  demonstrated	  that	  the	  influence	  of	  procedural	  pain	  on	  postnatal	  weight	  gain	  may	  be	  limited	  to	  the	  first	  few	  weeks	  of	  life	  (Vinall	  et	  al.).	  Importantly,	  this	  is	  the	  same	  time	  period	  when	  the	  infant	  undergoes	  the	  highest	  number	  of	  painful	  procedures	  (Carbajal	  et	  al.).	  This	  suggests	  that	  successful	  growth	  may	  depend	  more	  on	  adversities	  encountered	  in	  the	  early	  weeks	  of	  life,	  rather	  than	  the	  severity	  of	  a	  premature	  infant’s	  illness	  at	  birth.	  Vinall	  et	  al.	  concluded	  that	  the	  necessity	  and	  frequency	  of	  skin-­‐breaking	  procedures	  performed	  needs	  to	  be	  evaluated,	  with	  the	  goal	  of	  reducing	  unnecessary	  pain	  exposure.	  	  
Relationship	  between	  Oxytocin	  and	  Growth	  in	  Animal	  Studies	  
	  	   6	  Oxytocin	  has	  been	  found	  to	  play	  a	  central	  role	  in	  increasing	  levels	  of	  social	  interaction,	  maternal/infant	  boding,	  and	  anti-­‐stress	  effects	  (Uvnäs-­‐Moberg,	  Handlin,	  &	  Petersson,	  2015).	  It	  also	  has	  been	  shown	  to	  influence	  the	  secretion	  of	  many	  pituitary	  hormones,	  including	  growth	  hormone.	  Björkstrand,	  Hulting,	  and	  Uvnäs-­‐Moberg	  (1997),	  using	  an	  animal	  model,	  explored	  the	  effects	  of	  administration	  of	  variable	  doses	  of	  oxytocin	  on	  the	  release	  of	  growth	  hormone.	  Findings	  from	  the	  study	  demonstrated	  that	  oxytocin	  can	  have	  an	  inhibitory	  or	  stimulatory	  effect	  on	  growth	  hormone	  secretion.	  In	  low	  doses	  of	  oxytocin,	  release	  of	  growth	  hormone	  is	  stimulated.	  In	  contrast,	  higher	  doses	  of	  oxytocin	  resulted	  in	  inhibiting	  secretion	  of	  growth	  hormone.	  Early	  work	  by	  Uvnäs-­‐Moberg	  (1997)	  demonstrated	  that	  daily	  injections	  of	  oxytocin	  for	  a	  period	  of	  five	  days	  to	  rats	  resulted	  in	  clear	  anti-­‐stress	  behavior	  patterns.	  Further,	  female	  rats,	  in	  particular,	  also	  showed	  an	  increase	  in	  body	  weight	  following	  the	  five-­‐day	  administration	  of	  oxytocin.	  
Summary	  	   Premature	  infants,	  especially	  those	  born	  extremely	  premature,	  experience	  growth	  difficulties	  while	  in	  the	  NICU.	  By	  discharge,	  a	  significant	  number	  of	  these	  infants	  have	  attained	  weights	  below	  the	  10th	  percentile.	  Inadequate	  growth	  is	  most	  likely	  as	  a	  result	  of	  several	  interacting	  factors.	  An	  important	  contributing	  factor	  may	  be	  the	  number	  of	  painful	  procedures	  that	  the	  infant	  experiences.	  The	  stressful	  nature	  surrounding	  these	  procedures	  may	  impact	  growth.	  Oxytocin,	  an	  affliative	  hormone,	  may	  reduce	  stress	  and	  promote	  growth.	  
Methods	  	   This	  longitudinal,	  descriptive	  study	  was	  part	  of	  a	  larger	  study	  focused	  on	  the	  role	  of	  oxytocin	  in	  the	  neurodevelopment	  of	  extremely	  premature	  infants	  in	  the	  NICU.	  The	  study	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  received	  prior	  IRB	  approval.	  Premature	  infants	  were	  recruited	  from	  three	  Level	  III	  NICUs	  in	  central	  Ohio.	  Urinary	  oxytocin	  samples	  collected	  on	  Day	  of	  Life	  14	  and	  then	  weekly	  thereafter	  until	  the	  infant	  achieves	  34	  weeks	  corrected	  gestational	  age.	  Oxytocin	  levels	  determined	  using	  a	  commercially	  available	  ELISA	  assay	  kit	  (Enzo	  Life	  Sciences).	  Weekly	  weights	  recorded	  at	  the	  time	  of	  oxytocin	  sample	  collection	  and	  used	  to	  calculate	  growth	  velocity.	  The	  inclusion	  criteria	  included:	  Gestational	  age:	  25-­‐28	  6/7	  and	  free	  of	  major	  congenital	  or	  chromosomal	  abnormality,	  grade	  3	  or	  4	  intraventricular	  hemorrhage,	  hypoxic	  ischemic	  encephalopathy,	  metabolic	  disorders	  involving	  the	  adrenal	  system,	  and	  necrotizing	  enterocolitis	  requiring	  surgical	  intervention.	  	  
Results	  Twenty-­‐five	  extremely	  premature	  infants	  comprised	  the	  sample.	  The	  average	  birthweight	  was	  989.79	  ±	  263.30	  grams.	  Their	  average	  gestational	  age	  was	  26.67	  ±	  1.13	  weeks.	  The	  growth	  velocity	  average	  was	  27.87	  ±	  7.61	  grams.	  After	  analyzing	  all	  lab	  data,	  we	  were	  able	  to	  find	  average	  oxytocin	  levels	  in	  the	  urine	  at	  30	  and	  34.	  At	  30	  weeks,	  the	  average	  level	  was	  8909.00	  ±	  9925.41	  pg/ml,	  while	  at	  34	  weeks	  it	  was	  12,739	  ±	  13,414.	  69	  pg/ml.	  No	  significant	  relationships	  were	  found	  between	  oxytocin	  levels	  and	  growth	  velocity.	  	  
Discussion	  Our	  results	  showed	  no	  significant	  correlation	  between	  growth	  and	  oxytocin	  levels.	  The	  large	  variability	  in	  oxytocin	  levels,	  along	  with	  the	  small	  sample	  size,	  hindered	  detecting	  any	  significant	  relationships.	  However,	  fortunately,	  the	  majority	  of	  premature	  infants	  in	  this	  study	  had	  attained	  weights	  above	  the	  10th	  percentile.	  Facilitating	  the	  growth	  of	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  extremely	  premature	  infants	  remains	  a	  challenge	  within	  the	  stressful	  environment	  of	  the	  NICU.	  Identifying	  the	  factors	  that	  promote	  and	  hinder	  growth	  will	  require	  continued	  research	  in	  premature	  infants.	  We	  recommend	  oxytocin’s	  role	  in	  promoting	  growth	  be	  further	  studied	  with	  a	  larger	  sample.	  If	  a	  positive	  correlation	  is	  found,	  additional	  research	  should	  also	  include	  growth	  hormone	  levels,	  nutritional	  intake,	  and	  measures	  of	  stress	  in	  the	  NICU.	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